HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

AC-1202

an orally administered medium-chain (5-12 carbons) triglyceride; treatment of patients with mild-to-moderate AD improves memory and cognition

Networked: 2 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Lipids: 114793
- Glycerides: 109
  - Triglycerides: 40895
    - AC-1202: 2

Experts

1.	Barr, Linda J: 2 articles (08/2009 - 12/2008)
2.	Costantini, Lauren C: 2 articles (08/2009 - 12/2008)
3.	Henderson, Samuel T: 2 articles (08/2009 - 12/2008)
4.	Vogel, Janet L: 2 articles (08/2009 - 12/2008)
5.	Garvin, Fiona: 1 article (08/2009)
6.	Jones, Julie J: 1 article (08/2009)

Related Diseases

1.	Cognitive Dysfunction 12/03/2008 - "These data suggest that AC-1202 may be an effective treatment for cognitive dysfunction by providing an alternative substrate for use by glucose-compromised neurons."
2.	Alzheimer Disease (Alzheimer's Disease) 08/10/2009 - "Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial."
3.	Ketosis 08/10/2009 - "An oral ketogenic compound, AC-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance. "

Related Drugs and Biologics

1.	Glucose (Dextrose)